Skip to main content

Table 1 Characteristics of patients according to the expression status of estrogen receptor (ER) and progesterone receptor (PR)

From: The association between serum lipid levels and histological type of breast cancer

Variables

ER expression status

PR expression status

ER-BC (N = 70)

ER + BC (N = 150)

P

PR-BC (N = 73)

PR + BC (N = 144)

P

Age (years)

70

150

0.82

73

144

0.39

Less than50

31 (44.3%)

64 (42.7%)

29 (39.7%)

66 (45.8%)

50 and more

39 (55.7%)

86 (57.3%)

44 (60.3%)

78 (54.2%)

Height (cm)

160.2 ± 3.1

159.7 ± 4.9

0.53

159.1 ± 4.7

160.0 ± 4.7

0.18

Weight (kg)

62.0 ± 7.5

61.8 ± 8.5

0.90

60.8 ± 8.7

61.9 ± 8.5

0.36

BMI

70

149

0.15

73

143

0.35

Normal

40 (57.1%)

100 (67.1%)

42 (57.5%)

95 (66.4%)

Overweight

28 (40.0%)

41 (27.5%)

28 (38.4%)

41 (28.7%)

Obesity

2 (2.9%)

8 (5.4%)

3 (4.1%)

7 (4.9%)

Menopausal state

70

149

0.35

72

144

0.44

Premenopause

39 (55.7%)

73 (49.0%)

40 (55.6%)

72 (50.0%)

Postmenopause

31 (44.3%)

76 (51.0%)

32 (44.4%)

72 (50.0%)

Hypertension

70

149

0.10

72

144

0.60

Yes

15 (21.4%)

48 (32.2%)

19 (26.4%)

43 (29.9%)

No

55 (78.6%)

101 (67.8%)

53 (73.6%)

101 (70.1%)

Diabetes

70

149

0.11

72

144

0.87

Yes

3 (4.3%)

16 (10.7%)

6 (8.3%)

13 (9.0%)

No

67 (95.7%)

133 (89.3%)

66 (91.7%)

131 (91.0%)

Coronary heart disease

70

149

0.18a

72

144

0.67a

Yes

0

5 (3.4%)

1 (1.4%)

4 (2.8%)

No

70 (100%)

144 (96.6%)

71 (98.6%)

140 (97.2%)

BC family history

70

149

0.24a

72

144

0.26a

Yes

2 (2.9%)

1 (0.7%)

2 (2.8%)

1 (0.7%)

No

68 (97.1%)

148 (99.3%)

70 (97.2%)

143 (99.3%)

Parity

61

129

0.49a

63

125

0.61a

Nulliparous

2 (3.3%)

7 (5.4%)

4 (6.3%)

5 (4.0%)

Once or twice

57 (93.4%)

112 (86.8%)

56 (88.9%)

111 (88.8%)

More than twice

2 (3.3%)

10 (7.8%)

3 (4.8%)

9 (7.2%)

Miscarriage history

53

117

0.03

54

114

0.18

Non

25 (47.2%)

34 (29.1%)

24 (44.4%)

35 (30.7%)

Once or twice

25 (47.2%)

63 (53.8%)

25 (46.3%)

61 (53.5%)

More than twice

3 (5.7%)

20 (17.1%)

5 (9.3%)

18 (15.8%)

Location

70

150

0.61

73

144

0.70

Left

39 (55.7%)

78 (52.0%)

40 (54.8%)

75 (52.1%)

Right

31 (44.3%)

72 (48.0%)

33 (45.2%)

69 (47.9%)

Long diameter

67

148

 < 0.01

70

142

0.02

 ≤ 5 cm

51 (76.1%)

133 (89.9%)

54 (77.1%)

127 (89.4%)

 > 5 cm

16 (23.9%)

15 (10.1%)

16 (22.9%)

15 (10.6%)

WHO grade

64

129

 < 0.001

66

127

 < 0.001

I&II

28 (43.8%)

98 (76.0%)

29 (43.9%)

97 (76.4%)

III

36 (56.3%)

31 (24.0%)

37 (56.1%)

30 (23.6%)

Pathological type

70

150

0.46a

73

144

0.43a

Tis

5 (7.1%)

10 (6.7%)

5 (6.8%)

8 (5.6%)

Invasion, NST

64 (91.4%)

132 (88.0%)

67 (91.8%)

129 (89.6%)

Invasion, ST

1 (1.4%)

8 (5.3%)

1 (1.4%)

7 (4.9%)

  1. aFisher’s exact test
  2. ER + BC: ER-positive breast cancer; ER-BC: ER-negative breast cancer; PR + BC: PR-positive breast cancer; PR-BC: PR-negative breast cancer;